Therapeutics · Prescribing Safety

Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report

Dąbrowski FA, Sadlik N, Nowosielski K

Published January 2, 2021 International journal of surgery case reports
DOI 10.1016/j.ijscr.2020.12.093 PMID 33418422 PMC PMC7804344

Abstract

Introduction and Importance

Case report of patient with congenital lack of factor VII, suffering from recurrent hematomas and massive menstrual bleedings resulting in severe anemia and multiple hospitalization.

Case Presentation

Patient was diagnosed with endometrial hyperplasia and not responding to hormonal treatment and substitution with recombinant factor VII was not effective to reduce the bleedings. This case describes successful laparoscopic technique of using bipolar coagulation and non-absorbable clips.

Clinical Discussion

We describe premedication and post-surgical management - which we had to modify from this found in very scarce literature. Despite previous vaginal deliveries without any complications during the puerperium, 20 days after the surgery patient presented with intraperitoneal bleeding after stopping rFVIIa therapy. It was treated medically without the need for re-laparoscopy.

Conclusion

Laparoscopic surgery is possible in patients with lack and deficiency of FVIIa, but they need close post-operative surveillance and prolonged supplementation with recombinant FVIIa.

Topics

By this author

Therapeutics › Prescribing Safety › Off-Label Prescribing · Reproductive Surgery › Definitive and Ablative Procedures › Hysterectomy
Filip A Dąbrowski, Nikodem Sadlik, Krzysztof Nowosielski
F Dąbrowski, N Sadlik, K Nowosielski
PMID 33418422 33418422 DOI 10.1016/j.ijscr.2020.12.093 10.1016/j.ijscr.2020.12.093 Dąbrowski et al. 2021, Dąbrowski 2021